Home › Funds › De Lisle Partners LLP › ECG
De Lisle Partners LLP position in ECG
EVERUS CONSTR GROUP · Consumer Discretionary
De Lisle Partners LLP reported holding 233,759 shares of ECG (EVERUS CONSTR GROUP) in its Q3 2026 13F filing — a position valued at US$27.5M, representing 3.36% of its reported portfolio and ranking #3 among its reported holdings. De Lisle Partners LLP has disclosed ECG holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How De Lisle Partners LLP's ECG position evolved
De Lisle Partners LLP first disclosed a stake in ECG in Q4 2024 at 264,926 shares (US$17.4M). The position peaked in Q2 2026 at 361,159 shares, worth US$59.9M. Across 8 filings, De Lisle Partners LLP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 233,759 shares valued at US$27.5M — a reduction of -127,400 shares quarter over quarter.. Notable position changes include a 35% trim in Q3 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 264.93K | $17.42M | New |
| Q1 2025 | 305.40K | $11.34M | Add |
| Q2 2025 | 342.43K | $21.94M | Add |
| Q3 2025 | 362.43K | $31.06M | Add |
| Q4 2025 | 367.43K | $31.42M | Add |
| Q1 2026 | 367.43K | $43.36M | Hold |
| Q2 2026 | 361.16K | $59.94M | Reduce |
| Q3 2026 | 233.76K | $27.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ECG and 13F data
ECG (EVERUS CONSTR GROUP) is a Consumer Discretionary company. 67 other funds we track also report a position in ECG — the largest reported positions include WASATCH ADVISORS LP (US$143.1M), Forest Avenue Capital Management LP (US$137.2M), OBERWEIS ASSET MANAGEMENT INC/ (US$54.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ECG
- WASATCH ADVISORS LP 1.22M sh · $143.06M · Q3 2026
- Forest Avenue Capital Management LP 826.51K sh · $137.16M · Q2 2026
- OBERWEIS ASSET MANAGEMENT INC/ 328.18K sh · $54.46M · Q2 2026
- HAWK RIDGE CAPITAL MANAGEMENT LP 237.86K sh · $39.47M · Q2 2026
- ALGERT GLOBAL LLC 213.47K sh · $35.42M · Q2 2026
- Walleye Capital LLC 138.82K sh · $23.04M · Q2 2026
- NEEDHAM INVESTMENT MANAGEMENT LLC 126.50K sh · $20.99M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 125.00K sh · $20.74M · Q2 2026
- LONE PEAK GLOBAL INVESTORS LLC 115.44K sh · $19.16M · Q2 2026
More on De Lisle Partners LLP
FAQ
How long has De Lisle Partners LLP held ECG?
De Lisle Partners LLP has disclosed ECG holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is De Lisle Partners LLP's current position in ECG?
As of Q3 2026, De Lisle Partners LLP holds 233.76K shares of ECG (EVERUS CONSTR GROUP), valued at $27.47M, representing 3.36% of its reported portfolio and ranking #3.
Has De Lisle Partners LLP been buying or selling ECG?
In the latest 13F filing (Q3 2026), De Lisle Partners LLP reduced its position in ECG. The position peaked in Q2 2026 at 361.16K shares.
Which other funds hold ECG?
Other major institutional holders of ECG include WASATCH ADVISORS LP, Forest Avenue Capital Management LP, OBERWEIS ASSET MANAGEMENT INC/, among 67 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.